SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Bristol Myers’ Robert Plenge to Remain in Advisory Role Through March 2027

Robert Plenge will remain in an advisory capacity through March 2027 before departing, Bristol Myers said.

BMY

Related stories